外体YB-1通过MALAT1/miR-211-5p/FOXO轴促进卵巢的恢复
Mengxue Zhang1,2, Jie Xing1,3, Shijie Zhao1,4
1Reproductive Center, The Fourth Affiliated Hospital of Jiangsu University, 20 Zhengdong Road, Zhenjiang, Jiangsu, 212001, People's Republic of China.
Cell biology and toxicology
|May 3, 2024
概括
介酶干细胞衍生的细胞外囊泡通过输送YB-1蛋白来恢复过早卵巢衰竭 (POF) 的卵巢功能. 这种YB-1蛋白调节MALAT1/miR-211-5p/FOXO3通路,改善粒粉细胞功能和卵巢健康.
科学领域:
- 生殖生物学 生殖生物学
- 干细胞生物学 干细胞生物学
- 分子医学是分子医学.
背景情况:
- 过早的卵巢衰竭 (POF) 在40岁以下的女性中导致不孕.
- 介细胞干细胞衍生小细胞外囊 (MSCs-sEVs) 显示出对POF治疗的前景.
- 在POF中MSCs-sEVs的关键媒介和机制仍然不清楚.
研究的目的:
- 确定MSCs-sEV中负责恢复POF中的卵巢功能的关键介质.
- 阐明MSCs-sEVs发挥治疗作用的潜在分子机制.
- 研究YB-1蛋白在POF中的作用及其作为治疗点的潜力.
主要方法:
- 建立了POF的体外 (H2O2) 和体内 (CTX) 模型.
- 移植骨髓MSCs衍生的sEVs (BMSCs-sEVs) 进入POF大鼠模型.
- 利用了YB-1的耗尽,并分析了MALAT1/miR-211-5p/FOXO3轴.
- 在POF患者的血清和粒状细胞 (GCs) 中评估了YB-1水平.
主要成果:
- 在POF模型和患者中,YB-1蛋白的下调,与GC衰老相关.
- 在POF大鼠中,BMSCs-sEVs移植上调了YB-1,减弱了GC衰老,并改善了卵巢功能.
- YB-1 枯竭逆转了 BMSCs-sEVs 的治疗效果.
- YB-1稳定了MALAT1,它充当了miR-211-5p的ceRNA,增加了FOXO3水平并修复了卵巢功能.
结论:
- YB-1蛋白是BMSCs-sEVs在治疗POF时提供的关键调解剂.
- 治疗机制涉及YB-1介导的MALAT1/miR-211-5p/FOXO3轴的调节.
- 这一途径为管理早产卵巢衰竭提供了潜在的治疗标.
相关概念视频
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


